WHO list of priority medical devices for cancer management WHO Medical device technical series B r e a s t C e r v i c a l C h i l d h o o d C o l o n L e u k e m i a L u n g P r o s t a t e WHO list of priority medical devices for cancer management (WHO Medical device technical series) ISBN 978-92-4-156546-2 © World Health Organization 2017 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specifc organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. WHO list of priority medical devices for cancer management. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing. Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, fgures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party- owned component in the work rests solely with the user. General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specifc companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use. Design and layout of the document - Jillian Reichenbach Ott (Genève Design). Printed by the WHO Document Production Services, Geneva, Switzerland WHO list of priority medical devices for cancer management WHO Medical device technical series Acknowledgemen PHOTO CREDITS: Vaccination photo: WHO/PAHO 2014. Young girls getting Human papillomavirus (HPV) vaccination in their school, in São Paulo, Brazil. Pathology photo: Dr Jagdish Butany, Toronto General Hospital, Histology Laboratory, Toronto, Canada. Medical Imaging photo: Dr Adela Poitevin, Médica Sur, Tlalpan, Mexico City, Mexico. Radiotherapy photo: Dr Adela Poitevin, Mexico, Médica Sur, Tlalpan, Mexico City, Mexico. Nuclear Medicine photo: Dr Cecil Chow Robilotta, Centro de Medicina Nuclear, Instituto de Radiologia, São Paulo, Brazil. Palliative care photo: Anthony Greenwood, April 2016, Lancaster, UK. Photo provided by Dr Sheila Payne. Surgery photo: Dr André Ilbawi, May 2016, Butaro Hospital, Rwanda. Systemic therapy: Colleen Nixon, MSN RN CPHON, Nurse Educator, Boston Children’s Hospital Boston, MA. Photo provided by Lisa Morrissey, RN. Cover photo 1: Dr Diana Paez, IAEA. Photo was taken at the Department of Nuclear Medicine of the National Cancer Institute of Mexico City. Cover photo 2 - Pathology slide: Dr Jagdish Butany, Toronto General Hospital, Histology Laboratory, Toronto, Canada. Cover photo 3 - Nurse and child: Colleen Nixon, MSN RN CPHON, Nurse Educator, Boston Children’s Hospital Boston, MA. Cover photo 4 - Surgery: Dr André Ilbawi, May 2016, Butaro Hospital, Rwanda. Acknowledgements This project was developed by the World Health Organization (WHO) in response to the need for a model reference list of basic and priority medical devices required for cancer management, with the goal of increasing access to these medical devices especially in low- and middle-income countries . The project was developed under the overall coordination of Adriana Velazquez Berumen, Senior Advisor and Focal Point on Medical Devices from the Innovation, Access and Use unit of the Essential Medicines and Health Products Department, directed by Dr Suzanne Hill, under the Health Systems and Innovation Cluster. Special collaboration was received from Cherian Varghese, Coordinator, and Andre Ilbawi from the Noncommunicable Diseases Management Department, as well as from James Campbell, Director, Rania Kawar, Tana Wuliji and Teena Kunjumen of Health Workforce Department in WHO. Technical support was provided mainly by Gabriela Jimenez Moyao, WHO temporary staff in 2015-2016, and Natalia Rodriguez, intern in 2016. Additional support for the project was provided by Marina Alfons, Karin Diaconu, Mireille Goetghebeur, Antonio Migliore, and Miriam Mikhail. Final editorial review by Maurice Page and Corrado Gemma. WHO specially acknowledges May Abdel-Wahab and all staff from the Division of Human Health (NAHU) of the International Atomic Energy Agency (IAEA) for all the technical input provided. The primary fnancial support for this study was provided by the OPEC Fund for International Development (OFID). WHO acknowledges and is most grateful to all the participants of the meetings and consultations, the Steering Committee members and the experts who provided advice in the development of this document, as follows: April 2015 - General Consultation Participants: May Abdel-Wahab, Nicholas Adjabu, Benjamin O. Anderson, Damien Bertrand, Vikram Bhadrasain, Jolanta Bilinska, Jagdish Butany, Eduardo Cazap, Nicole Denjoy, Ahmed Elzawawy, Alexandru Eniu, Temidayo Fadelu, Shamiram Feinglass, John Flanigan, Birgit Fleurent, Xavier Franz, Ophira Ginsburg, Zelalem Gizachew, Mary Gospodarowicz, S. W. Gunn, Leonie Hyme, Geoffrey Ibbott, Kinga Jamphel, Muditha Jayatilaka, Roberta Joppi, Mahlet Kife, Jitendar Kumar Sharma, Gilberto Lopes, Ratko Magjarevic, Alessandro Masellis, Joan McClure, Manuel Antonio Munoz Aviles, Mulundi Mwanahamuntu, Dieter Nuernberg, Kof Mensah Nyarko, Jackson Orem, Maurice Page, Groesbeck Parham, Youlin Qiao, Sandra Rocha, Daniela Rodriguez, Ludo Scheerlinck, Julie Torode. From WHO Regional Offces: Adham Ismail Abdel Moneim, Hanne Bak Pedersen. From WHO Noncommunicable Diseases and Mental Health Cluster: Onyema Ajuebor, Marilys Corbex, Leanne Riley, Andreas Ullrich, Cherian Varghese. From WHO Health Systems and Innovation Cluster: Service Delivery and Safety Department: Katthayana Aparicio Reyes, Marie-Charlotte Bouesseau, Meena Nathan Cherian, Nittita Prasopa-Plaizier; Health Workforce Department: Annette Nkowane; Essential Medicines And Health Products: Marina Ashraf Alfons, Karin Daniela Diaconu, Gilles Forte, Gabriela Jimenez Moyao, Nicola Magrini, Robyn Meurant, Antonio Migliore, Miriam Mikhail, Megan Smith, Adriana Velazquez Berumen. June-July 2015 - Field interviews in National Oncology Institute (INCAN) in Mexico: Directors: Abelardo Meneses Garcia y Ángel Herrera Gómez; Gynaecology David Isla Ortiz; Urology, Miguel Ángel Jiménez Ríos; Breast, Enrique Bargalló Rocha; Lung, Edgardo Jiménez Fuentes; Colo-rectal, Horacio Noé López Basave and Itzel Vela; bone marrow, Ana Irma; Radiotherapy, Aida Mota García; Brachytherapy, Guadalupe Elizabeth Trejo Durán; Clinical Laboratory , Patricia Montoya Pérez; Pathology, Hector Maldonado M; Cytology,. Lorena Flores Hernández; Palliative care, Silvia Allende; Chemotherapy, Catalina Aguilar González; Systemic Therapy, Odilia Tellez Miranda; Imaging , Yolanda Villaseñor Navarro; Nuclear Medicine, Osvaldo García Pérez; Physicist, Jesús del Real; Endoscopy, Angélica Hernández Guerrero; Surgery, Gonzalo Montalvo Esquivel and Biomedical Engineering, Sandra Rocha Nava. September 2015 - Steering Committee Meeting Participants: Benjamin O. Anderson, Ronald Bauer, Gouri Bhattacharyya, Bjorn Fahlgren, Mireille Goetghebeur, Mary Gospodarowicz, Rosa Giuliani, Gilberto Lopes, Valentino Mvanga, Jitendar Sharma Kumar, Lawrence Shulman, WHO Staff: Adham Ismail Abdel Moneim, Sheick Oumar Coulibaly, Suzanne Hill, Gabriela Jimenez Moyao, Cherian Varghese; Adriana Velazquez Berumen. Observers: Ileana Freige, Miriam Mikhail, Ameel Mohammad, Julie Torode.